Open AccessS0815 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease
Author(s) -
Geert DʼHaens,
Stefan Schreiber,
Édouard Louis,
Bruce E. Sands,
Elisa Gomez Valderas,
Debra L. Miller,
Noah Agada,
April N. Naegeli,
Paul Pollack,
Jochen Schmitz,
J van der Woude,
Jarosław Kierkuś,
William J. Sandborn
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705308.49396.cf
Subject(s) - medicine , gastroenterology , calprotectin , ulcerative colitis , biomarker , placebo , c reactive protein , microscopic colitis , faecal calprotectin , crohn's disease , inflammatory bowel disease , acute phase protein , inflammation , immunology , disease , pathology , biochemistry , chemistry , alternative medicine